Skip to main content
Clinical Trials/ACTRN12608000577314
ACTRN12608000577314
Completed
Phase 4

A prospective randomized controlled trial comparing survival outcome between patients with resectable large hepatocellular carcinoma (HCC) underwent preoperative transarterial chemoembolization (TACE) with partial hepatectomy and partial hepatectomy alone

Eastern Hepatobiliary Surgery Hospital0 sites100 target enrollmentNovember 12, 2008

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Eastern Hepatobiliary Surgery Hospital
Enrollment
100
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 12, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Preoperative diagnosis of HCC \> or \=5 cm in diameter suitable for partial hepatectomy

Exclusion Criteria

  • Received other treatment before; history or presence of other malignancies; inadequate liver function

Outcomes

Primary Outcomes

Not specified

Similar Trials